【非洲科技·非洲】AMR in Africa: The data gap behind the crisis

aipl1234

#非洲

中文导读

行业领域 (Verticals) 创业公司 (Startups) 生活与职场 (Life and Work) 财经 (Money) 企业与政策 (Enterprise/Policy) 专栏 (Columns) 投资者问答 (Ask an Investor) 焦点关注 (Centre Stage) 咖啡访

关注我们：
X (X平台)
LinkedIn (领英)
TikTok (抖音国际版)
WhatsApp (瓦次普)
Facebook (脸书)
Instagram (照片墙)
YouTube (优兔)

LinkedIn (领英)
TikTok (抖音)
WhatsApp (瓦茨阿普)
Facebook (脸书)
Instagram (照片墙)
YouTube (优兔/油管)
Verticals (垂直领域)

市场情报仪表盘

X LinkedIn (领英) TikTok (抖音) WhatsApp (WhatsApp) Facebook (脸书) Instagram (照片墙) YouTube (优兔)
版权所有 ©2026。保留所有权利。隐私与条款。



原文原文 / Original Text

Verticals StartupsLife and WorkMoneyEnterprise/Policy Columns Ask an InvestorCentre StageCoffee WithDay 1-1000Delve into AIDigital NomadsFollow the MoneyJourneysMy Life in TechNewsletter

XLinkedInTikTokWhatsAppFacebookInstagramYouTubeFollow us

XLinkedInTikTokWhatsAppFacebookInstagramYouTubeVerticals

Market Intel Dashboard

This contributor piece by Chinaza Esiaba was first published on TechCabal Insights. 

For years, antimicrobial resistance (AMR) in Africa has been described through increasingly stark numbers. AMR happens when bacteria and other microbes evolve to resist the drugs used to treat them, making common infections harder to cure and, in some cases, untreatable. A Lancet analysis estimated that western sub-Saharan Africa had the world’s highest death rate attributable to bacterial AMR in 2019: 27.3 deaths per 100,000 people. The figures establish the scale of the threat. They also expos

The World Health Organisation (WHO) estimates that one in five laboratory-confirmed bacterial infections in its African Region in 2023 was resistant to antibiotics. That estimate cannot capture infections that are never tested. The visibility gap extends beyond Africa. 48% of countries did not report resistance data to the WHO’s Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2023, and about half of those that reported lacked systems to produce reliable data.

This is a public health challenge with a health tech dimension. AI diagnostics and prescribing tools depend on laboratories that can test infections, records that link results to patients, and surveillance systems that turn individual tests into evidence about local resistance. For governments and investors, building those connections may be the more immediate opportunity.

本文为英文资讯，中文内容由机器翻译生成，仅供参考。详情请阅读文末原文。

—— 资讯转载说明 ——
本文由非洲论坛根据公开信息整理，供中国读者查阅，不代表本站立场。
来源：TechCabal Africa (https://techcabal.com/)
原文链接：https://techcabal.com/2026/10/06/amr-in-africa-the-data-gap/
转载请遵守原发布方版权与引用规定。